Rilzabrutinib
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications
Emerging pharmacotherapies for chronic spontaneous urticaria: spotlight on BTK inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: August 19, 2026
Bruton Tyrosine Kinase as Therapeutic Target in Cardiovascular Diseases-Executive Summary.
Journal: Thrombosis and haemostasis
Published: July 08, 2026
Rilzabrutinib for persistent or chronic immune thrombocytopenia (ITP): a Bruton tyrosine kinase inhibitor that can target multiple pathophysiological pathways.
Journal: Expert review of hematology
Published: May 10, 2026
A New Drug Target in Allergic Diseases: Bruton Tyrosine Kinase.
Journal: Journal of investigational allergology & clinical immunology
Published: April 27, 2026
Time to Meaningful Clinical Response Across Approved and Emerging Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Network Meta-Analysis.
Journal: Journal of clinical medicine
Published: April 18, 2026
Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders.
Journal: Pharmacological research
Published: March 31, 2026
Justifying score interpretation thresholds for the Asthma Control Questionnaire (ACQ-5) in a contemporary asthma patient population.
Journal: Journal of patient-reported outcomes
Published: February 11, 2026
A phase 2 trial of rilzabrutinib in IgG4-related disease.
Journal: Annals of the rheumatic diseases
Published: February 03, 2026
Immune thrombocytopenia: contemporary pathophysiology, treatment gaps, and the role of novel mechanisms in patient-centered care.
Journal: The American journal of managed care
Published: January 28, 2026
Properties of FDA-approved small molecule protein kinase inhibitors: A 2026 update.
Journal: Pharmacological research
Published: January 20, 2026
Rilzabrutinib and the evolving landscape of oral therapies for uncontrolled asthma.
Journal: The Lancet. Respiratory medicine
Published: December 29, 2025
Immune thrombocytopenia: Evolving mechanistic understanding and clinical development of new therapies.
Journal: Tzu chi medical journal
Published: December 18, 2025
Last Updated: 09/26/2026